White label – Pompe disease - ClinicalTrials.eu

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Not recruiting

3 1
Investigated Drugs:
- Asundexian
+14
Study Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
Investigated Drugs:
Study on the Effectiveness of Biomarker Staging Compared to Conventional Staging in Women with Early-Stage Endometrial Cancer Using Paclitaxel and Carboplatin

Not recruiting

3 1 1 1
Investigated Diseases:
- Endometrial cancer
Investigated Drugs:
- Carboplatin
- Paclitaxel
Study on Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Urothelial Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Enfortumab Vedotin
- Pembrolizumab
Study on Methadone and Placebo for Pain Relief in Elderly Patients with Hip Fractures

Not recruiting

3 1 1
Investigated Diseases:
- Femoral neck fracture
- Femur fracture
Investigated Drugs:
- Levomethadone Hydrochloride
- Sodium Chloride
Study on Preoperative Treatment for HER2 Positive Breast Cancer Using Docetaxel, Pertuzumab, and Trastuzumab in Patients with Primary Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms

Not recruiting

2 1
Investigated Diseases:
- Cutaneous lupus erythematosus
- Systemic lupus erythematosus
Investigated Drugs:
- Humanised Igg1K Monoclonal Antibody Against Interferon Beta
Study on the Safety and Effectiveness of BLU-222 Alone and with Drug Combination for Patients with Advanced Solid Tumors, Including Breast and Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Drugs:
Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

Not recruiting

3 1 1 1
Investigated Diseases:
- Osteogenesis imperfecta
Investigated Drugs:
+3
Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Not recruiting

3 1 1 1
Investigated Diseases:
- Myelodysplastic syndrome
Investigated Drugs:
- Epoetin Alfa
- Luspatercept
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies